{"id":8951,"date":"2025-06-26T12:35:22","date_gmt":"2025-06-26T17:35:22","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?page_id=8951"},"modified":"2025-08-26T19:36:23","modified_gmt":"2025-08-27T00:36:23","slug":"compassionate-use-policy","status":"publish","type":"page","link":"https:\/\/nanostherapeutics.com\/ar\/compassionate-use-policy\/","title":{"rendered":"\u0633\u064a\u0627\u0633\u0629 \u0627\u0644\u0627\u0633\u062a\u062e\u062f\u0627\u0645 \u0627\u0644\u0631\u062d\u064a\u0645"},"content":{"rendered":"<div data-elementor-type=\"wp-page\" data-elementor-id=\"8951\" class=\"elementor elementor-8951\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-c9cd9ec elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"c9cd9ec\" data-element_type=\"section\" data-e-type=\"section\">\r\n\t\t\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\r\n\t\t\t\t\r\n\t\t\t\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-705608a\" data-id=\"705608a\" data-element_type=\"column\" data-e-type=\"column\">\r\n\r\n\t\t\t\t\r\n\t\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\r\n\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5da0260 elementor-widget elementor-widget-heading\" data-id=\"5da0260\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">\u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u064a\u0643\u0633<\/br>\n\u0633\u064a\u0627\u0633\u0629 \u0627\u0644\u0648\u0635\u0648\u0644 \u0627\u0644\u0645\u0648\u0633\u0639\u0629<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-bab875b elementor-widget elementor-widget-spacer\" data-id=\"bab875b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-af5128a elementor-widget elementor-widget-text-editor\" data-id=\"af5128a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p style=\"font-weight: 400;\">\u064a\u064f\u0637\u0644\u0642 \u0639\u0644\u064a\u0647 \u0623\u062d\u064a\u0627\u0646\u064b\u0627 &quot;\u0627\u0644\u0627\u0633\u062a\u062e\u062f\u0627\u0645 \u0627\u0644\u0631\u062d\u064a\u0645&quot;\u060c \u0648\u064a\u0639\u062f \u0627\u0644\u0648\u0635\u0648\u0644 \u0627\u0644\u0645\u0648\u0633\u0639 \u0645\u0633\u0627\u0631\u064b\u0627 \u0645\u062d\u062a\u0645\u0644\u0627\u064b \u0644\u0644\u0645\u0631\u064a\u0636 \u0627\u0644\u0630\u064a \u064a\u0639\u0627\u0646\u064a \u0645\u0646 \u0645\u0631\u0636 \u0645\u0627\u00a0<a href=\"https:\/\/www.fda.gov\/news-events\/expanded-access\/expanded-access-keywords-definitions-and-resources\">\u062d\u0627\u0644\u0629 \u062a\u0647\u062f\u062f \u0627\u0644\u062d\u064a\u0627\u0629 \u0639\u0644\u0649 \u0627\u0644\u0641\u0648\u0631 \u0623\u0648 \u0645\u0631\u0636 \u0623\u0648 \u062d\u0627\u0644\u0629 \u062e\u0637\u064a\u0631\u0629<\/a>\u00a0\u0644\u0644\u0648\u0635\u0648\u0644 \u0625\u0644\u0649\u00a0<a href=\"https:\/\/www.fda.gov\/news-events\/expanded-access\/expanded-access-keywords-definitions-and-resources\">\u0627\u0644\u0645\u0646\u062a\u062c \u0627\u0644\u0637\u0628\u064a \u0627\u0644\u062a\u062d\u0642\u064a\u0642\u064a<\/a>\u00a0(\u062f\u0648\u0627\u0621 \u0623\u0648 \u062c\u0647\u0627\u0632 \u0628\u064a\u0648\u0644\u0648\u062c\u064a \u0623\u0648 \u0637\u0628\u064a) \u0644\u0644\u0639\u0644\u0627\u062c \u062e\u0627\u0631\u062c \u0627\u0644\u062a\u062c\u0627\u0631\u0628 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629 \u0639\u0646\u062f\u0645\u0627 \u0644\u0627 \u062a\u062a\u0648\u0641\u0631 \u062e\u064a\u0627\u0631\u0627\u062a \u0639\u0644\u0627\u062c \u0628\u062f\u064a\u0644\u0629 \u0642\u0627\u0628\u0644\u0629 \u0644\u0644\u0645\u0642\u0627\u0631\u0646\u0629 \u0623\u0648 \u0645\u0631\u0636\u064a\u0629.\u00a0<\/p><p style=\"font-weight: 400;\">\u062a\u0631\u0643\u0632 \u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u0643\u0633 \u0639\u0644\u0649 \u0625\u0646\u062c\u0627\u062d \u0639\u0645\u0644\u064a\u0629 \u062a\u0637\u0648\u064a\u0631 \u0639\u0642\u0627\u0631\u0647\u0627 \u0627\u0644\u062a\u062c\u0631\u064a\u0628\u064a\u060c MCO-010\u060c \u0645\u0646 \u062e\u0644\u0627\u0644 \u0627\u062c\u062a\u064a\u0627\u0632 \u0627\u0644\u0625\u062c\u0631\u0627\u0621\u0627\u062a \u0627\u0644\u062a\u0646\u0638\u064a\u0645\u064a\u0629 \u0644\u0639\u0644\u0627\u062c \u0627\u0644\u062a\u0647\u0627\u0628 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0635\u0628\u0627\u063a\u064a \u0648\u0645\u0631\u0636 \u0633\u062a\u0627\u0631\u063a\u0627\u0631\u062f\u062a\u060c \u0625\u064a\u0645\u0627\u0646\u064b\u0627 \u0645\u0646\u0647\u0627 \u0628\u0623\u0646 \u0630\u0644\u0643 \u0633\u064a\u062a\u064a\u062d \u0625\u0645\u0643\u0627\u0646\u064a\u0629 \u0648\u0635\u0648\u0644 \u0623\u0643\u0628\u0631 \u0639\u062f\u062f \u0645\u0646 \u0627\u0644\u0645\u0631\u0636\u0649 \u0625\u0644\u0649 \u0639\u0642\u0627\u0631\u0647\u0627 \u0641\u064a \u0623\u0642\u0635\u0631 \u0648\u0642\u062a \u0645\u0645\u0643\u0646. \u0625\u0636\u0627\u0641\u0629\u064b \u0625\u0644\u0649 \u0630\u0644\u0643\u060c \u0644\u0645 \u064a\u062a\u0645 \u0628\u0639\u062f\u064f \u062a\u062d\u062f\u064a\u062f \u0633\u0644\u0627\u0645\u0629 \u0648\u0641\u0639\u0627\u0644\u064a\u0629 \u0639\u0642\u0627\u0631\u0646\u0627 \u0627\u0644\u062a\u062c\u0631\u064a\u0628\u064a\u060c \u0641\u0636\u0644\u064b\u0627 \u0639\u0646 \u0623\u0641\u0636\u0644 \u0637\u0631\u0642 \u0625\u064a\u0635\u0627\u0644\u0647. \u0644\u0630\u0627\u060c \u0644\u0627 \u062a\u064f\u0642\u062f\u0645 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u0643\u0633 \u0639\u0627\u062f\u0629\u064b \u0628\u0631\u0646\u0627\u0645\u062c \u0627\u0644\u0648\u0635\u0648\u0644 \u0627\u0644\u0645\u0648\u0633\u0639 \u0625\u0644\u0649 \u0639\u0642\u0627\u0631\u0647\u0627 \u0627\u0644\u062a\u062c\u0631\u064a\u0628\u064a\u060c \u0628\u0644 \u062a\u064f\u0634\u062c\u0639 \u0627\u0644\u0645\u0631\u0636\u0649 \u0639\u0644\u0649 \u0627\u0633\u062a\u0634\u0627\u0631\u0629 \u0623\u0637\u0628\u0627\u0626\u0647\u0645 \u0628\u0634\u0623\u0646 \u0623\u0647\u0644\u064a\u062a\u0647\u0645 \u0644\u0644\u0645\u0634\u0627\u0631\u0643\u0629 \u0641\u064a \u0623\u064a \u0645\u0646 \u062a\u062c\u0627\u0631\u0628\u0646\u0627 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629 \u0627\u0644\u062a\u064a \u0642\u062f \u062a\u064f\u062d\u0633\u0651\u0646 \u062d\u0627\u0644\u062a\u0647\u0645.<\/p><p style=\"font-weight: 400;\">\u0645\u0639 \u0630\u0644\u0643\u060c \u0642\u062f \u0646\u0646\u0638\u0631\u060c \u0641\u064a \u062d\u0627\u0644\u0627\u062a \u0627\u0633\u062a\u062b\u0646\u0627\u0626\u064a\u0629\u060c \u0641\u064a \u0637\u0644\u0628\u0627\u062a \u0627\u0644\u0623\u0637\u0628\u0627\u0621 \u0627\u0644\u0645\u0631\u062e\u0635\u064a\u0646 \u0641\u064a \u0627\u0644\u0648\u0644\u0627\u064a\u0627\u062a \u0627\u0644\u0645\u062a\u062d\u062f\u0629 \u0627\u0644\u0623\u0645\u0631\u064a\u0643\u064a\u0629 \u0644\u0645\u0631\u0636\u0627\u0647\u0645 \u0627\u0644\u0645\u0635\u0627\u0628\u064a\u0646 \u0628\u0627\u0644\u062a\u0647\u0627\u0628 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0635\u0628\u0627\u063a\u064a \u0623\u0648 \u0645\u0631\u0636 \u0633\u062a\u0627\u0631\u063a\u0627\u0631\u062f\u062a \u0627\u0644\u0630\u064a\u0646 \u0627\u0633\u062a\u0646\u0641\u062f\u0648\u0627 \u062c\u0645\u064a\u0639 \u0627\u0644\u0639\u0644\u0627\u062c\u0627\u062a \u0627\u0644\u0628\u062f\u064a\u0644\u0629 \u0627\u0644\u0645\u062a\u0627\u062d\u0629. \u064a\u062c\u0628 \u0623\u0646 \u062a\u064f\u0631\u0633\u0644 \u0637\u0644\u0628\u0627\u062a \u0627\u0644\u0648\u0635\u0648\u0644 \u0627\u0644\u0645\u0648\u0633\u0639 \u0645\u0646 \u0627\u0644\u0637\u0628\u064a\u0628 \u0627\u0644\u0645\u0639\u0627\u0644\u062c \u0639\u0628\u0631 \u0627\u0644\u0628\u0631\u064a\u062f \u0627\u0644\u0625\u0644\u0643\u062a\u0631\u0648\u0646\u064a \u0625\u0644\u0649: <a href=\"mailto:info@nanostherapeutics.com\">info@nanostherapeutics.com<\/a>. \u0648\u0633\u0646\u0633\u0639\u0649 \u0644\u0644\u0631\u062f \u0639\u0644\u0649 \u0647\u0630\u0647 \u0627\u0644\u0637\u0644\u0628\u0627\u062a \u062e\u0644\u0627\u0644 10 \u0623\u064a\u0627\u0645 \u0639\u0645\u0644.<\/p><p style=\"font-weight: 400;\">\u0633\u0648\u0641 \u062a\u0623\u062e\u0630 \u0634\u0631\u0643\u0629 Nanscope Therapeutics \u0641\u064a \u0627\u0644\u0627\u0639\u062a\u0628\u0627\u0631 \u0627\u0644\u0639\u0648\u0627\u0645\u0644 \u0627\u0644\u062a\u0627\u0644\u064a\u0629 \u0644\u0644\u0627\u0633\u062a\u062e\u062f\u0627\u0645 \u0627\u0644\u0631\u062d\u064a\u0645 \u0627\u0644\u0645\u062d\u062a\u0645\u0644:<\/p><ul style=\"font-weight: 400;\"><li>\u0627\u0644\u062d\u0627\u0644\u0629 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629 \u0644\u0644\u0645\u0631\u064a\u0636 \u0628\u0645\u0627 \u0641\u064a \u0630\u0644\u0643 \u0645\u0627 \u0625\u0630\u0627 \u0643\u0627\u0646\u062a \u062c\u0645\u064a\u0639 \u062e\u064a\u0627\u0631\u0627\u062a \u0627\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u0645\u0639\u062a\u0645\u062f\u0629 \u0623\u0648 \u0627\u0644\u062a\u062c\u0627\u0631\u0628 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629 \u0642\u062f \u0627\u0633\u062a\u0646\u0641\u062f\u062a<\/li><li>\u0645\u0627 \u0625\u0630\u0627 \u0643\u0627\u0646 \u0627\u0644\u0637\u0628\u064a\u0628 \u0627\u0644\u0645\u0639\u0627\u0644\u062c \u064a\u0639\u062a\u0642\u062f \u0623\u0646 \u0627\u0644\u0641\u0648\u0627\u0626\u062f \u0627\u0644\u0645\u062d\u062a\u0645\u0644\u0629 \u0644\u062f\u0648\u0627\u0626\u0646\u0627 \u0627\u0644\u062a\u062c\u0631\u064a\u0628\u064a \u0633\u0648\u0641 \u062a\u0641\u0648\u0642 \u0623\u064a \u0645\u062e\u0627\u0637\u0631 \u0645\u062d\u062a\u0645\u0644\u0629 \u0639\u0644\u0649 \u0627\u0644\u0645\u0631\u064a\u0636<\/li><li>\u0642\u062f\u0631\u0629 \u0627\u0644\u0637\u0628\u064a\u0628 \u0627\u0644\u0645\u0639\u0627\u0644\u062c \u0639\u0644\u0649 \u0625\u0628\u0644\u0627\u063a \u0627\u0644\u0645\u0631\u064a\u0636 \u0628\u0634\u0643\u0644 \u0645\u0646\u0627\u0633\u0628 \u0628\u0627\u0644\u0645\u062e\u0627\u0637\u0631 \u0648\u0627\u0644\u0641\u0648\u0627\u0626\u062f \u0627\u0644\u0645\u062d\u062a\u0645\u0644\u0629 \u0644\u0644\u0627\u0633\u062a\u062e\u062f\u0627\u0645 \u0627\u0644\u0645\u0642\u062a\u0631\u062d \u0644\u0639\u0642\u0627\u0631\u0646\u0627 \u0627\u0644\u062a\u062c\u0631\u064a\u0628\u064a \u062d\u062a\u0649 \u064a\u062a\u0645\u0643\u0646 \u0627\u0644\u0645\u0631\u064a\u0636 \u0645\u0646 \u062a\u0642\u062f\u064a\u0645 \u0645\u0648\u0627\u0641\u0642\u0629 \u0645\u0633\u062a\u0646\u064a\u0631\u0629 \u0648\u0627\u0633\u062a\u0639\u062f\u0627\u062f \u062c\u0645\u064a\u0639 \u0627\u0644\u0623\u0637\u0631\u0627\u0641 \u0644\u0644\u062a\u0648\u0642\u064a\u0639 \u0639\u0644\u0649 \u0625\u0642\u0631\u0627\u0631\u00a0<\/li><li>\u0642\u062f\u0631\u0629 \u0627\u0644\u0637\u0628\u064a\u0628 \u0627\u0644\u0645\u0639\u0627\u0644\u062c \u0639\u0644\u0649 \u062a\u0642\u062f\u064a\u0645 \u062f\u0648\u0627\u0621\u0646\u0627 \u0627\u0644\u062a\u062c\u0631\u064a\u0628\u064a \u0628\u0627\u0633\u062a\u062e\u062f\u0627\u0645 \u0627\u0644\u062d\u0642\u0646 \u062f\u0627\u062e\u0644 \u0627\u0644\u062c\u0633\u0645 \u0627\u0644\u0632\u062c\u0627\u062c\u064a \u0627\u0644\u0630\u064a \u064a\u062a\u0645 \u0625\u0646\u0634\u0627\u0624\u0647 \u0641\u064a \u062a\u062c\u0627\u0631\u0628\u0646\u0627 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629<\/li><li>\u0627\u062d\u062a\u0645\u0627\u0644 \u0642\u064a\u0627\u0645 \u0627\u0644\u0633\u0644\u0637\u0627\u062a \u0627\u0644\u062a\u0646\u0638\u064a\u0645\u064a\u0629 \u0648\u0645\u062c\u0627\u0644\u0633 \u0627\u0644\u0645\u0631\u0627\u062c\u0639\u0629 \u0627\u0644\u0645\u0624\u0633\u0633\u064a\u0629 (IRB&#039;s) \u0628\u0645\u0631\u0627\u062c\u0639\u0629 \u0648\u0627\u0644\u0645\u0648\u0627\u0641\u0642\u0629 \u0639\u0644\u0649 \u0627\u0644\u0648\u0635\u0648\u0644 \u0627\u0644\u0645\u0648\u0633\u0639 \u0644\u0644\u0645\u0631\u064a\u0636 \u0641\u064a \u0627\u0644\u0648\u0642\u062a \u0627\u0644\u0645\u0646\u0627\u0633\u0628<\/li><li>\u062a\u062c\u0631\u0628\u062a\u0646\u0627 \u0627\u0644\u0633\u0627\u0628\u0642\u0629 \u0645\u0639 \u0645\u0648\u0642\u0639 IRB \u0648\u0627\u0644\u062a\u0632\u0627\u0645 \u0627\u0644\u0637\u0628\u064a\u0628 \u0627\u0644\u0645\u0639\u0627\u0644\u062c \u0628\u0627\u0644\u062d\u0635\u0648\u0644 \u0639\u0644\u0649 \u0645\u0648\u0627\u0641\u0642\u0629 IRB \u0648\u0627\u0644\u062d\u0641\u0627\u0638 \u0639\u0644\u0649 \u062a\u0637\u0628\u064a\u0642 \u0627\u0644\u062f\u0648\u0627\u0621 \u0627\u0644\u062a\u062c\u0631\u064a\u0628\u064a \u0627\u0644\u062c\u062f\u064a\u062f (IND)<\/li><li>\u0627\u0644\u0639\u0631\u0636 \u0627\u0644\u0645\u062a\u0627\u062d \u0645\u0646 \u0627\u0644\u0645\u062e\u062f\u0631\u0627\u062a \u0627\u0644\u062a\u062d\u0642\u064a\u0642\u064a\u0629<\/li><li>\u062a\u0623\u062b\u064a\u0631 \u062a\u0648\u0641\u064a\u0631 \u0627\u0644\u0648\u0635\u0648\u0644 \u0627\u0644\u0645\u0648\u0633\u0639 \u0625\u0644\u0649 \u0627\u0644\u0645\u0648\u0627\u0631\u062f \u0627\u0644\u0645\u062e\u0635\u0635\u0629 \u0644\u0628\u0631\u0627\u0645\u062c\u0646\u0627 \u0627\u0644\u062a\u0646\u0645\u0648\u064a\u0629\u00a0<\/li><li>\u0639\u0648\u0627\u0645\u0644 \u0623\u062e\u0631\u0649 \u0642\u062f \u0646\u0631\u0627\u0647\u0627 \u0645\u0646\u0627\u0633\u0628\u0629<\/li><\/ul><p style=\"font-weight: 400;\">\u062a\u062d\u062a\u0641\u0638 \u0634\u0631\u0643\u0629 Nanoscope Therapeutics, Inc. \u0628\u0627\u0644\u062d\u0642 \u0641\u064a \u0645\u0631\u0627\u062c\u0639\u0629 \u0647\u0630\u0647 \u0627\u0644\u0633\u064a\u0627\u0633\u0629 \u0623\u0648 \u0625\u064a\u0642\u0627\u0641\u0647\u0627 \u062f\u0648\u0646 \u0625\u0634\u0639\u0627\u0631 \u0645\u0633\u0628\u0642.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t<\/section>\r\n\t\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Nanoscope Therapeutics, Inc. Expanded Access Policy Sometimes called \u201ccompassionate use\u201d, expanded access is a potential pathway for a patient with an\u00a0immediately life-threatening condition or serious disease or condition\u00a0to gain access to an\u00a0investigational medical product\u00a0(drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.\u00a0 Nanoscope [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":8971,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-8951","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Compassionate Use Policy - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ar\/compassionate-use-policy\/\" \/>\n<meta property=\"og:locale\" content=\"ar_AR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Compassionate Use Policy - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ar\/compassionate-use-policy\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-27T00:36:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u062f\u0642\u064a\u0642\u062a\u0627\u0646\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/compassionate-use-policy\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/compassionate-use-policy\\\/\",\"name\":\"Compassionate Use Policy - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/compassionate-use-policy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/compassionate-use-policy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg\",\"datePublished\":\"2025-06-26T17:35:22+00:00\",\"dateModified\":\"2025-08-27T00:36:23+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/compassionate-use-policy\\\/#breadcrumb\"},\"inLanguage\":\"ar\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/compassionate-use-policy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/compassionate-use-policy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg\",\"width\":1200,\"height\":242},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/compassionate-use-policy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Compassionate Use Policy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ar\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u0633\u064a\u0627\u0633\u0629 \u0627\u0644\u0627\u0633\u062a\u062e\u062f\u0627\u0645 \u0627\u0644\u0631\u062d\u064a\u0645 - \u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u0643\u0633","description":"\u062a\u064f\u0639\u062f\u0651 \u0645\u0646\u0635\u0629 \u0627\u0644\u0623\u0648\u0628\u0633\u064a\u0646 \u0645\u062a\u0639\u062f\u062f\u0629 \u0627\u0644\u062e\u0635\u0627\u0626\u0635 (MCO) \u0627\u0644\u062e\u0627\u0635\u0629 \u0628\u0646\u0627 \u0627\u0644\u0623\u0648\u0644\u0649 \u0645\u0646 \u0646\u0648\u0639\u0647\u0627 \u0627\u0644\u062a\u064a \u0623\u062b\u0628\u062a\u062a \u0642\u062f\u0631\u062a\u0647\u0627 \u0639\u0644\u0649 \u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0628\u0635\u0631 \u0644\u0645\u0631\u0636\u0649 \u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0630\u064a\u0646 \u064a\u0639\u0627\u0646\u0648\u0646 \u0645\u0646 \u0641\u0642\u062f\u0627\u0646 \u0634\u062f\u064a\u062f \u0644\u0644\u0628\u0635\u0631 \u0641\u064a \u0627\u0644\u062a\u062c\u0627\u0631\u0628 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629. \u0648\u0642\u062f \u0637\u0648\u0651\u0631\u062a \u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062a\u0642\u0646\u064a\u0629 MCO-010\u060c \u0648\u0647\u064a \u0627\u0644\u062a\u0642\u0646\u064a\u0629 \u0627\u0644\u0623\u0648\u0644\u0649 \u0648\u0627\u0644\u0648\u062d\u064a\u062f\u0629 \u0645\u0646 \u0646\u0648\u0639\u0647\u0627 \u0641\u064a \u0645\u062c\u0627\u0644 \u0639\u0644\u0645 \u0627\u0644\u0628\u0635\u0631\u064a\u0627\u062a \u0627\u0644\u0648\u0631\u0627\u062b\u064a\u0629\u060c \u0648\u0627\u0644\u062a\u064a \u062a\u062a\u0645\u064a\u0632 \u0628\u0646\u0637\u0627\u0642\u0647\u0627 \u0627\u0644\u0648\u0627\u0633\u0639 \u0648\u0627\u0633\u062a\u062c\u0627\u0628\u062a\u0647\u0627 \u0627\u0644\u0633\u0631\u064a\u0639\u0629 \u0648\u062d\u0633\u0627\u0633\u064a\u062a\u0647\u0627 \u0627\u0644\u0641\u0627\u0626\u0642\u0629\u060c \u0648\u0647\u064a \u062a\u0642\u0646\u064a\u0629 \u0645\u0633\u062a\u0642\u0644\u0629 \u0639\u0646 \u0627\u0644\u062c\u064a\u0646\u0627\u062a \u0627\u0644\u0645\u0633\u062a\u062e\u062f\u0645\u0629 \u0641\u064a \u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0628\u0635\u0631.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ar\/compassionate-use-policy\/","og_locale":"ar_AR","og_type":"article","og_title":"Compassionate Use Policy - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ar\/compassionate-use-policy\/","og_site_name":"Nanoscope Therapeutics","article_modified_time":"2025-08-27T00:36:23+00:00","og_image":[{"width":1200,"height":242,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@NSTherapeutics","twitter_misc":{"\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631":"\u062f\u0642\u064a\u0642\u062a\u0627\u0646"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/compassionate-use-policy\/","url":"https:\/\/nanostherapeutics.com\/compassionate-use-policy\/","name":"\u0633\u064a\u0627\u0633\u0629 \u0627\u0644\u0627\u0633\u062a\u062e\u062f\u0627\u0645 \u0627\u0644\u0631\u062d\u064a\u0645 - \u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u0643\u0633","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/compassionate-use-policy\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/compassionate-use-policy\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg","datePublished":"2025-06-26T17:35:22+00:00","dateModified":"2025-08-27T00:36:23+00:00","description":"\u062a\u064f\u0639\u062f\u0651 \u0645\u0646\u0635\u0629 \u0627\u0644\u0623\u0648\u0628\u0633\u064a\u0646 \u0645\u062a\u0639\u062f\u062f\u0629 \u0627\u0644\u062e\u0635\u0627\u0626\u0635 (MCO) \u0627\u0644\u062e\u0627\u0635\u0629 \u0628\u0646\u0627 \u0627\u0644\u0623\u0648\u0644\u0649 \u0645\u0646 \u0646\u0648\u0639\u0647\u0627 \u0627\u0644\u062a\u064a \u0623\u062b\u0628\u062a\u062a \u0642\u062f\u0631\u062a\u0647\u0627 \u0639\u0644\u0649 \u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0628\u0635\u0631 \u0644\u0645\u0631\u0636\u0649 \u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0634\u0628\u0643\u064a\u0629 \u0627\u0644\u0630\u064a\u0646 \u064a\u0639\u0627\u0646\u0648\u0646 \u0645\u0646 \u0641\u0642\u062f\u0627\u0646 \u0634\u062f\u064a\u062f \u0644\u0644\u0628\u0635\u0631 \u0641\u064a \u0627\u0644\u062a\u062c\u0627\u0631\u0628 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629. \u0648\u0642\u062f \u0637\u0648\u0651\u0631\u062a \u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062a\u0642\u0646\u064a\u0629 MCO-010\u060c \u0648\u0647\u064a \u0627\u0644\u062a\u0642\u0646\u064a\u0629 \u0627\u0644\u0623\u0648\u0644\u0649 \u0648\u0627\u0644\u0648\u062d\u064a\u062f\u0629 \u0645\u0646 \u0646\u0648\u0639\u0647\u0627 \u0641\u064a \u0645\u062c\u0627\u0644 \u0639\u0644\u0645 \u0627\u0644\u0628\u0635\u0631\u064a\u0627\u062a \u0627\u0644\u0648\u0631\u0627\u062b\u064a\u0629\u060c \u0648\u0627\u0644\u062a\u064a \u062a\u062a\u0645\u064a\u0632 \u0628\u0646\u0637\u0627\u0642\u0647\u0627 \u0627\u0644\u0648\u0627\u0633\u0639 \u0648\u0627\u0633\u062a\u062c\u0627\u0628\u062a\u0647\u0627 \u0627\u0644\u0633\u0631\u064a\u0639\u0629 \u0648\u062d\u0633\u0627\u0633\u064a\u062a\u0647\u0627 \u0627\u0644\u0641\u0627\u0626\u0642\u0629\u060c \u0648\u0647\u064a \u062a\u0642\u0646\u064a\u0629 \u0645\u0633\u062a\u0642\u0644\u0629 \u0639\u0646 \u0627\u0644\u062c\u064a\u0646\u0627\u062a \u0627\u0644\u0645\u0633\u062a\u062e\u062f\u0645\u0629 \u0641\u064a \u0627\u0633\u062a\u0639\u0627\u062f\u0629 \u0627\u0644\u0628\u0635\u0631.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/compassionate-use-policy\/#breadcrumb"},"inLanguage":"ar","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/compassionate-use-policy\/"]}]},{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/nanostherapeutics.com\/compassionate-use-policy\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg","width":1200,"height":242},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/compassionate-use-policy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Compassionate Use Policy"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u0639\u0644\u0627\u062c\u0627\u062a \u0627\u0644\u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628","description":"\u0625\u0639\u0627\u062f\u0629 \u0646\u0648\u0631 \u0627\u0644\u0623\u0645\u0644","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ar"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u0634\u0631\u0643\u0629 \u0646\u0627\u0646\u0648\u0633\u0643\u0648\u0628 \u062b\u064a\u0631\u0627\u0628\u064a\u0648\u062a\u0643\u0633","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/pages\/8951","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/comments?post=8951"}],"version-history":[{"count":10,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/pages\/8951\/revisions"}],"predecessor-version":[{"id":9452,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/pages\/8951\/revisions\/9452"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/media\/8971"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ar\/wp-json\/wp\/v2\/media?parent=8951"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}